Wait...
Search Global Export Import Trade Data
Recent Searches: No Recent Searches

Shantha Biotechnics begins commercial production at new unit.


Date: 01-06-2016
Subject: Shantha Biotechnics begins commercial production at new unit
HYDERABAD: Sanofi Pasteur, the vaccines division of Sanofi, today said commercial production at its affiliate Shantha Biotechnics' new vaccines manufacturing facility began on May 25.

The new facility, located in Special Economic Zone (SEZ) Muppireddipalli near here, has the latest technology to produce vaccines that meet global standards of quality, the company said in a statement.

Construction of the 19,000 sq-meter facility began in 2010 and the site has received approvals from the Indian regulatory authorities and the World Health Organisation.

Shailesh Ayyangar, Country Chair and Managing Director - Sanofi India Ltd, said, "With this dedicated site for vaccines, the company is reinforcing its commitment towards 'Make in India' and disease prevention and public health in India and also across the world."

"This site is a part of over Rs 5,500 crore investment undertaken by Sanofi since acquisition of Shantha Biotechnics in 2009. We thank Government of Telangana for their encouragement and support in our endeavours," Ayyangar added.

The new filling facility will be used for producing vaccines against multiple diseases starting with Shan5 (a five-in-one, high-quality vaccine that provides effective protection for children from 6 weeks of age against five diseases: diphtheria, tetanus, pertussis, Hib and hepatitis B (DTP - HepB - Hib)) and pediatric pentavalent vaccine, which provides protection against five diseases in one shot.

Mahesh Bhalgat, Executive Director and Chief Operating Officer, Shantha Biotechnics, India, said, "At Shantha Biotechnics, our mission is to develop, produce and market affordable vaccines. We are committed to providing our customers with the assurance of products that meet best-in-class international standards for purity, potency and safety."

Source : economictimes.indiatimes.com

Get Sample Now

Which service(s) are you interested in?
 Export Data
 Import Data
 Both
 Buyers
 Suppliers
 Both
OR
 Exim Help
+


What is New?

Date: 18-09-2025
Corrigendum
Corrigendum to Notification No. 9/2025 – Central Tax (Rate) dated 17.09.2025

Date: 17-09-2025
Notification No. 13/2025-Central Tax (Rate)
Seeks to amend Notification No. 21/2018- Central Tax (Rate) dated 26.07.2018.

Date: 17-09-2025
Notification No. 14/2025-Central Tax (Rate)
Seeks to notify GST rate for bricks.

Date: 17-09-2025
Notification No. 37/ 2025-Customs
Seeks to amend Notification No.19/2019-Customs dated 06.07.2019

Date: 17-09-2025
Notification No. 38/ 2025-Customs
Seeks to amend Notification No.29/2025-Customs dated 09.05.2025

Date: 17-09-2025
Notification No. 39/2025-Customs
Seeks to amend Notification No.50/2017-Customs, dated 30.06.2017

Date: 17-09-2025
NOTIFICATIONNo. 15/2025 – Central Tax
Seeks to exempt taxpayer with annual turnover less than Rs 2 Crore from filing annual return.

Date: 17-09-2025
NOTIFICATION No. 16/2025–Central Tax
Seeks to notify clauses (ii), (iii) of section 121, section 122 to section 124 and section 126 to 134 of Finance Act, 2025 to come into force.

Date: 17-09-2025
Notification No. 12/2025-Central Tax (Rate)
Seeks to amend Notification No. 8/2018- Central Tax (Rate) dated 25.01.2018.

Date: 17-09-2025
NOTIFICATION No. 14/2025 – Central Tax
Seeks to notify category of persons under section 54(6).



Exim Guru Copyright © 1999-2025 Exim Guru. All Rights Reserved.
The information presented on the site is believed to be accurate. However, InfodriveIndia takes no legal responsibilities for the validity of the information.
Please read our Terms of Use and Privacy Policy before you use this Export Import Data Directory.

EximGuru.com

C/o InfodriveIndia Pvt Ltd
F-19, Pocket F, Okhla Phase-I
Okhla Industrial Area
New Delhi - 110020, India
Phone : 011 - 40703001